Nicholas Papajohn, MD
Dermatology · Miramar Beach, FLNPI 1548425812
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Pfizer accounts for 62.0% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2019 at $16,351 and has fallen 92.4% since, to $1,238 in 2025. Among dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 617 payments — averaging $43.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$17K
- AbbVie$3K
- Sun Pharmaceutical Industries Inc.$991
- Johnson & Johnson$951
- Sanofi$900
- Amgen$743
- plus $4K from 32 others
What the payments were for
- Speaking & faculty fees$15,25057%
- Travel & lodging$2621%
- Food & beverage$10,89941%
- Education$2531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,663 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 18 | $216,599 |
| Dupixent PenDupilumab | 33 | $125,320 |
| Clobetasol Propionate | 104 | $5,174 |
| Doxycycline Hyclate | 83 | $2,483 |
| Ketoconazole | 135 | $2,159 |
| Triamcinolone Acetonide | 136 | $1,842 |
| ValacyclovirValacyclovir Hcl | 50 | $1,331 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 14 | $1,293 |
| Minocycline Hcl | 34 | $1,174 |
| Desonide | 23 | $1,127 |
| Metronidazole | 12 | $1,113 |
| Fluocinonide | 33 | $1,073 |
| Mometasone Furoate | 53 | $911 |
| Clindamycin Phosphate | 24 | $787 |
| Hydroxychloroquine Sulfate | 11 | $672 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Miramar Beach
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.